Competitive Advantage in New Patent Regime: A Study of the Indian Pharmaceutical Industry
Indore Management Journal, Special Issue 2012
18 Pages Posted: 9 Apr 2012 Last revised: 25 Feb 2019
Date Written: April 9, 2012
The introduction of product patent regime in 2005 forced the firms in the Indian Pharmaceutical Industry (IPI) to rethink their sources of competitive advantage. The absence of an appropriate funding mechanism through the Indian government and the acquisition of Indian pharmaceutical firms by MNCs have added to the woes. This study mainly focuses on how firms in the IPI would respond in such a scenario.
Keywords: Indian Pharmaceutical Industry, productpatent regime, competitive advantage, resource-based view (RBV), government support, strategic options, key capabilities
Suggested Citation: Suggested Citation